{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:20:12Z","timestamp":1790774412197,"version":"4.1.0"},"reference-count":92,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2014,6,17]],"date-time":"2014-06-17T00:00:00Z","timestamp":1402963200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0099320","type":"journal-article","created":{"date-parts":[[2014,6,17]],"date-time":"2014-06-17T20:33:15Z","timestamp":1403037195000},"page":"e99320","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":101,"title":["The VMAT-2 Inhibitor Tetrabenazine Affects Effort-Related Decision Making in a Progressive Ratio\/Chow Feeding Choice Task: Reversal with Antidepressant Drugs"],"prefix":"10.1371","volume":"9","author":[{"given":"Patrick A.","family":"Randall","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christie A.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric J.","family":"Nunes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha E.","family":"Yohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Nowak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bilal","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saagar","family":"Pandit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V. Kiran","family":"Vemuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Makriyannis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Younis","family":"Baqi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christa E.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merce","family":"Correa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Salamone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,6,17]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0166-4328(02)00282-6","article-title":"Motivational views of reinforcement: implications for understanding the behavioral functions of nucleus accumbens dopamine","volume":"137","author":"JD Salamone","year":"2002","journal-title":"Behav Brain Res"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.neuron.2012.10.021","article-title":"The mysterious motivational functions of mesolimbic dopamine","volume":"76(3)","author":"JD Salamone","year":"2012","journal-title":"Neuron"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0166-2236(03)00233-9","article-title":"Parsing Reward","volume":"26 (9)","author":"KC Berridge","year":"2003","journal-title":"Trends Neurosci"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1460-9568.2011.07916.x","article-title":"Dopaminergic enhancement of local food-seeking is under global homeostatic control","volume":"35(1)","author":"JA Beeler","year":"2012","journal-title":"Eur J Neurosci"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s00213-006-0668-9","article-title":"Effort-related functions of nucleus accumbens dopamine and associated forebrain circuits","volume":"191(3)","author":"JD Salamone","year":"2007","journal-title":"Psychopharmacology"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s00213-006-0528-7","article-title":"A role for mesencephalic dopamine in activation: commentary on Berridge (2006)","volume":"191(3)","author":"TW Robbins","year":"2007","journal-title":"Psychopharmacology"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"16585","DOI":"10.1523\/JNEUROSCI.3958-10.2010","article-title":"The flexible approach hypothesis: unification of effort and cue-responding hypotheses for the role of nucleus accumbens dopamine in the activation of reward-seeking behavior","volume":"30","author":"SM Nicola","year":"2010","journal-title":"J Neurosci"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.neuron.2013.04.010","article-title":"Invigoration of reward seeking by cue and proximity encoding in the nucleus accumbens","volume":"78(5)","author":"VB McGinty","year":"2013","journal-title":"Neuron"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0149-7634(96)00017-6","article-title":"Behavioral functions of nucleus accumbens dopamine: empirical and conceptual problems with the anhedonia hypothesis","volume":"21","author":"JD Salamone","year":"1997","journal-title":"Neurosci Biobehav Rev"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"6475","DOI":"10.1523\/JNEUROSCI.23-16-06475.2003","article-title":"Functional specialization within medial frontal cortex of the anterior cingulate for evaluating effort-related decisions","volume":"23(16)","author":"ME Walton","year":"2003","journal-title":"J Neurosci"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1038\/sj.npp.1300966","article-title":"Mice with chronically elevated dopamine exhibit enhanced motivation, but not learning, for a food reward","volume":"31","author":"B Cagniard","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1038\/sj.npp.1301565","article-title":"Dopaminergic and glutamatergic regulation of effort- and delay-based decision making","volume":"33","author":"SB Floresco","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"9037","DOI":"10.1523\/JNEUROSCI.1525-08.2008","article-title":"Nucleus accumbens adenosine A2A receptors regulate exertion of effort by acting on the ventral striatopallidal pathway","volume":"28(36)","author":"S Mingote","year":"2008","journal-title":"J Neurosci"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1093\/cercor\/bhn241","article-title":"Prefrontostriatal circuitry regulates effort-related decision making","volume":"19(10)","author":"W Hauber","year":"2009","journal-title":"Cereb Cortex"},{"key":"ref15","volume":"37(9 Pt A)","unstructured":"Nunes EJ, Randall PA, Podurgiel S, Correa M, Salamone JD (2013) Nucleus accumbens neurotransmission and effort-related choice behavior in food motivation: Effects of drugs acting on dopamine, adenosine, and muscarinic acetylcholine receptors. Neurosci Biobehav Rev <volume>37(9 Pt A)<\/volume>: : 2015\u20132025."},{"key":"ref16","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.1523\/JNEUROSCI.4515-08.2009","article-title":"Effort-based cost-benefit valuation and the human brain","volume":"29(14)","author":"PL Croxson","year":"2009","journal-title":"J Neurosci"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3758\/CABN.9.1.16","article-title":"Effort discounting in human nucleus accumbens","volume":"9(1)","author":"MM Botvinick","year":"2009","journal-title":"Cogn Affect Behav Neurosci"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1152\/jn.00027.2010","article-title":"Choosing to make an effort: the role of striatum in signaling physical effort of a chosen action","volume":"104(1)","author":"IT Kurniawan","year":"2010","journal-title":"J Neurophysiol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"16597","DOI":"10.1523\/JNEUROSCI.4387-11.2011","article-title":"Amping up effort: effects of d-amphetamine on human effort-based decision-making","volume":"31(46)","author":"MC Wardle","year":"2011","journal-title":"J Neurosci"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"6170","DOI":"10.1523\/JNEUROSCI.6459-11.2012","article-title":"Dopaminergic mechanisms of individual differences in human effort-based decision-making","volume":"32(18)","author":"MT Treadway","year":"2012","journal-title":"J Neurosci"},{"key":"ref21","first-page":"251","article-title":"Amygdala-prefrontal cortical circuitry regulates effort-based decision making","volume":"17(2)","author":"SB Floresco","year":"2007","journal-title":"Cereb Cortex"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.neuroscience.2007.12.034","article-title":"Forebrain circuitry involved in effort-related choice: Injections of the GABAA agonist muscimol into ventral pallidum alter response allocation in food-seeking behavior","volume":"152(2)","author":"AM Farrar","year":"2008","journal-title":"Neuroscience"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0166-4328(94)90108-2","article-title":"Anhedonia or anergia? Effects of haloperidol and nucleus accumbens dopamine depletion on instrumental response selection in a T-maze cost\/benefit procedure","volume":"65(2)","author":"JD Salamone","year":"1994","journal-title":"Behav Brain Res"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s00213-008-1174-z","article-title":"Intra-accumbens injections of the adenosine A(2A) agonist CGS 21680 affect effort-related choice behavior in rats","volume":"199(4)","author":"L Font","year":"2008","journal-title":"Psychopharmacology"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.neuroscience.2009.12.056","article-title":"Nucleus accumbens and effort-related functions: behavioral and neural markers of the interactions between adenosine A2A and dopamine D2 receptors","volume":"166(4)","author":"AM Farrar","year":"2010","journal-title":"Neuroscience"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3758\/s13415-011-0068-4","article-title":"Motivational states influence effort-based decision making in rats: the role of dopamine in the nucleus accumbens","volume":"12","author":"B Mai","year":"2012","journal-title":"Cogn Affect Behav Neurosci"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00213-008-1441-z","article-title":"The adenosine A2A antagonist MSX-3 reverses the effects of the dopamine antagonist haloperidol on effort-related decision making in a T-maze cost\/benefit procedure","volume":"204","author":"AM Mott","year":"2009","journal-title":"Psychopharmacology"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1016\/j.neuropharm.2011.12.033","article-title":"Adenosine A2A receptor antagonism and genetic deletion attenuate the effects of dopamine D2 antagonism on effort-based decision making in mice","volume":"62","author":"M Pardo","year":"2012","journal-title":"Neuropharmacology"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1037\/a0014625","article-title":"Dopamine modulates effort based decision making in rats","volume":"123(2)","author":"ME Bardgett","year":"2009","journal-title":"Behav Neurosci"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/BF02245659","article-title":"Haloperidol and nucleus accumbens dopamine depletion suppress lever pressing for food but increase free food consumption in a novel food choice procedure","volume":"104(4)","author":"JD Salamone","year":"1991","journal-title":"Psychopharmacology (Berl)"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s00213-001-0994-x","article-title":"Dopamine antagonists alter response allocation but do not suppress appetite for food in rats: contrast between the effects of SKF 83566, raclopride and fenfluramine on a concurrent choice task","volume":"160","author":"JD Salamone","year":"2002","journal-title":"Psychopharmacology"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"e47934","DOI":"10.1371\/journal.pone.0047934","article-title":"Dopaminergic modulation of effort-related choice behavior as assessed by a progressive ratio chow feeding choice task: pharmacological studies and the role of individual differences","volume":"7(10)","author":"PA Randall","year":"2012","journal-title":"PLoS One"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0091-3057(01)00524-X","article-title":"D1 or D2 antagonism in nucleus accumbens core or dorsomedial shell suppresses lever pressing for food but leads to compensatory increases in chow consumption","volume":"69","author":"KL Nowend","year":"2001","journal-title":"Pharmacol Biochem Behav"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0166-4328(95)00151-4","article-title":"Nucleus accumbens dopamine depletions alter relative response allocation in a T-maze cost\/benefit task","volume":"74","author":"MS Cousins","year":"1996","journal-title":"Behav Brain Res"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s00213-007-0988-4","article-title":"Cannabinoid CB1 antagonists and dopamine antagonists produce different effects on a task involving response allocation and effort-related choice in food-seeking behavior","volume":"196(4)","author":"KS Sink","year":"2008","journal-title":"Psychopharmacology"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s00213-006-0554-5","article-title":"Adenosine A(2A) receptor antagonism reverses the effects of dopamine receptor antagonism on instrumental output and effort-related choice in the rat: implications for studies of psychomotor slowing","volume":"191(3)","author":"AM Farrar","year":"2007","journal-title":"Psychopharmacology"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.bbr.2009.02.021","article-title":"Differential actions of adenosine A1 and A2A antagonists on the effort-related effects of dopamine D2 antagonism","volume":"201(1)","author":"JD Salamone","year":"2009","journal-title":"Behav Brain Res"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00213-008-1396-0","article-title":"The adenosine A2A antagonist MSX-3 reverses the effort-related effects of dopamine blockade: differential interaction with D1 and D2 family antagonists","volume":"203(3)","author":"LT Worden","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.neuroscience.2010.05.068","article-title":"Differential effects of selective adenosine antagonists on the effort-related impairments induced by dopamine D1 and D2 antagonism","volume":"170(1)","author":"EJ Nunes","year":"2010","journal-title":"Neuroscience"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.pbb.2012.06.009","article-title":"The novel adenosine A(2A) antagonist prodrug MSX-4 is effective in animal models related to motivational and motor functions","volume":"102(4)","author":"JL Santerre","year":"2012","journal-title":"Pharmacol Biochem Behav"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2174\/157340006776875914","article-title":"Nucleus accumbens dopamine and the forebrain circuitry involved in behavioral activation and effort-related decision making: implications for understanding anergia and psychomotor slowing in depression","volume":"2","author":"JD Salamone","year":"2006","journal-title":"Curr Psychiatry Rev"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s00213-013-3285-4","article-title":"Effort-related motivational effects of the pro-inflammatory cytokine interleukin 1-beta: studies with the concurrent fixed ratio 5\/chow feeding choice task","volume":"231","author":"EJ Nunes","year":"2014","journal-title":"Psychopharmacology"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"19120","DOI":"10.1523\/JNEUROSCI.2730-13.2013","article-title":"Effort-Related Motivational Effects of the VMAT-2 Inhibitor Tetrabenazine: Implications for Animal Models of the Motivational Symptoms of Depression","volume":"33(49)","author":"EJ Nunes","year":"2013","journal-title":"J Neurosci"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"7","DOI":"10.4088\/JCP.v63n0102","article-title":"The psychopharmacology of energy and fatigue","volume":"63(1)","author":"SM Stahl","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/da.22199","article-title":"Clinical relevance of fatigue as a residual symptom in major depressive disorder","volume":"31(3)","author":"M Fava","year":"2014","journal-title":"Depress Anxiety"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/00004714-199908000-00008","article-title":"Open study of the catechol-O-methyltransferase inhibitor tolcapone in major depressive disorder","volume":"19","author":"M Fava","year":"1999","journal-title":"J Clin Psychopharmacol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"e6598","DOI":"10.1371\/journal.pone.0006598","article-title":"Worth the \u2018EEfRT\u2019? The effort expenditure for rewards task as an objective measure of motivation and anhedonia","volume":"4(8)","author":"MT Treadway","year":"2009","journal-title":"PLoS One"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1037\/a0028813","article-title":"Effort-based decision-making in major depressive disorder: a translational model of motivational anhedonia","volume":"121(3)","author":"MT Treadway","year":"2012","journal-title":"J Abnorm Psychol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/0014-2999(84)90562-4","article-title":"Tetrabenazine-induced depletion of brain monoamines: characterization and interaction with selected antidepressants","volume":"102","author":"DJ Pettibone","year":"1984","journal-title":"Eur J Pharmacol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/0278-5846(95)00124-E","article-title":"TJS-010, a new prescription of oriental medicine, antagonizes tetrabenazine-induced suppression of spontaneous locomotor activity in rats","volume":"19(5)","author":"AJ Tanra","year":"1995","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref51","volume":"9(62)","unstructured":"Frank S (2009) Tetrabenazine as anti-chorea therapy in Huntington disease: an open-label continuation study. Huntington Study Group\/TETRA-HD Investigators. BMC Neurol <volume>9(62)<\/volume>.."},{"key":"ref52","doi-asserted-by":"crossref","first-page":"657","DOI":"10.2147\/NDT.S6430","article-title":"Tetrabenazine: the first approved drug for the treatment of chorea in US patients with Huntington disease","volume":"6","author":"S Frank","year":"2010","journal-title":"Neuropsychiatr Dis Treat"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.amjopharm.2010.08.006","article-title":"Tetrabenazine, a monoamine-depleting drug used in the treatment of hyperkinetic movement disorders","volume":"8(4)","author":"DR Guay","year":"2010","journal-title":"Am J Geriatr Pharmacother"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1007\/BF00427445","article-title":"Cerebromicrocirculatory defects in animal model of depression","volume":"84(2)","author":"SH Preskorn","year":"1984","journal-title":"Psychopharmacology (Berl)"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/0006-3223(86)90190-3","article-title":"Amitriptyline normalizes tetrabenazine-induced changes in cerebral microcirculation","volume":"21(5\u20136)","author":"TA Kent","year":"1986","journal-title":"Biol Psychiatry"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.nucmedbio.2010.01.006","article-title":"In vivo studies of the SERT-selective [18F]FPBM and VMAT2-selective [18F]AV-133 radiotracers in a rat model of Parkinson&apos;s disease","volume":"37(4)","author":"JL Wang","year":"2010","journal-title":"Nucl Med Biol"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00213-011-2198-3","article-title":"Stimulant effects of adenosine antagonists on operant behavior: differential actions of selective A2A and A1 antagonists","volume":"216(2)","author":"PA Randall","year":"2011","journal-title":"Psychopharmacology"},{"key":"ref58","unstructured":"Keppel G (1991) Design and analysis: a researcher&apos;s handbook. Prentice Hall, Englewood Cliffs."},{"key":"ref59","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/mp.2013.57","article-title":"Increasing dopamine D2 receptor expression in the adult nucleus accumbens enhances motivation","volume":"18","author":"P Trifilieff","year":"2013","journal-title":"Mol Psychiatry"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1124\/jpet.108.149617","article-title":"Characterization of the potent and highly selective A2A receptor antagonists preladenant and SCH 412348 [7-[2-[4-2,4-difluorophenyl]-1-piperazinyl]ethyl]-2-(2-furanyl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine] in rodent models of movement disorders and depression","volume":"330(1)","author":"RA Hodgson","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"ref61","first-page":"64","article-title":"Biochemical and anatomical substrates of depression and sickness behavior","volume":"47(1)","author":"TC Hanff","year":"2010","journal-title":"Isr J Psychiatry Relat Sci"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.pbb.2013.10.022","article-title":"Antidepressant-like activity of the adenosine A<sub>2A<\/sub> receptor antagonist, istradefylline (KW-6002), in the forced swim test and the tail suspension test in rodents","volume":"114\u2013115","author":"K Yamada","year":"2013","journal-title":"Pharmacol Biochem Behav"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1016\/j.clinthera.2010.11.011","article-title":"Antidepressant monotherapy: A claims database analysis of treatment changes and treatment duration","volume":"32(12)","author":"D Milea","year":"2010","journal-title":"Clin Ther"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1017\/S1461145704004729","article-title":"The many faces of fatigue in major depressive disorder","volume":"8","author":"K Demyttenaere","year":"2005","journal-title":"Int J Neuropsychopharmacology"},{"key":"ref65","first-page":"1287","article-title":"Efficacy of bupropion and the selective serotonin reuptake inhibitors in the treatment of major depressive disorder with high levels of anxiety (anxious depression): a pooled analysis of 10 studies","volume":"69(8)","author":"GI Papakostas","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.mehy.2006.11.009","article-title":"Therapeutic implication of cocaine- and amphetamine-regulated transcript (CART) in the treatment of depression","volume":"69(1)","author":"CU Pae","year":"2007","journal-title":"Med Hypotheses"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5607\/en.2011.20.1.1","article-title":"MAO-inhibitors in Parkinson&apos;s Disease","volume":"20(1)","author":"P Riederer","year":"2011","journal-title":"Exp Neurobiol"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.jad.2013.07.023","article-title":"Predictors of relapse in patients with major depressive disorder in a 52-week, fixed dose, double blind, randomized trial of selegiline transdermal system (STS)","volume":"151(3)","author":"S Jang","year":"2013","journal-title":"J Affect Disord"},{"key":"ref69","volume":"15","unstructured":"Sclar DA, Cohen LJ, Portland KB (2013) Selegiline transdermal system: use pattern and adherence in patients with major depressive disorder. Prim Care Companion CNS Disord <volume>15<\/volume> (1)."},{"key":"ref70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0278-5846(87)90026-1","article-title":"The effect of monoamine oxidase inhibitors compared with classical tricyclic antidepressants on learned helplessness paradigm","volume":"11(1)","author":"P Martin","year":"1987","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.nlm.2009.11.003","article-title":"Cognitive aspects of congenital learned helplessness and its reversal by the monoamine oxidase (MAO)-B inhibitor deprenyl","volume":"93(2)","author":"D Schulz","year":"2010","journal-title":"Neurobiol Learn Mem"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1192\/bjp.132.2.133","article-title":"Catechol-O-methyl transferase activity in patients with depressive illness and anxiety states","volume":"132","author":"R Shulman","year":"1978","journal-title":"Br J Psychiatry"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jad.2010.08.009","article-title":"The functional Val158Met polymorphism in catechol-O-methyltransferase (COMT) is associated with depression and motivation in men from a Swedish population-based study","volume":"129(1)","author":"E \u00c5berg","year":"2011","journal-title":"J Affect Disord"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/mds.21878","article-title":"Movement Disorder Society of Australia Clinical Research and Trials Group; QUEST-AP Study Group. Quality of life in early Parkinson&apos;s disease treated with levodopa\/carbidopa\/entacapone","volume":"24(1)","author":"VS Fung","year":"2009","journal-title":"Mov Disord"},{"key":"ref75","first-page":"972","article-title":"3-Methoxytyramine is the major metabolite of released dopamine in the rat frontal cortex","volume":"63(3)","author":"F Karoum","year":"1994","journal-title":"J Neurochem"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1038\/sj.npp.1300218","article-title":"COMT mRNA expression in the dorsolateral prefrontal cortex of patients with schizophrenia","volume":"28","author":"M Matsumoto","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"10196","DOI":"10.1523\/JNEUROSCI.0665-07.2007","article-title":"Site-specific role of COMT in dopamine overflow within prefrontal cortex and dorsal striatum","volume":"27(38)","author":"L Yavich","year":"2007","journal-title":"J Neurosci"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/00008877-199406000-00012","article-title":"Tolcapone: a potential new antidepressant detected in a novel animal model of depression","volume":"5(3)","author":"JL Moreau","year":"1994","journal-title":"Behav Pharmacol"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2147\/PPA.S4084","article-title":"Levodopa\/carbidopa and entacapone in the treatment of Parkinson&apos;s disease: efficacy, safety and patient preference","volume":"3","author":"T M\u00fcller","year":"2009","journal-title":"Patient Prefer Adherence"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/BF01245227","article-title":"Dopamine and depression","volume":"91","author":"AS Brown","year":"1993","journal-title":"J Neural Transm Gen Sect"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1038\/npp.2012.69","article-title":"Acute stress induces selective alterations in cost\/benefit decision-making","volume":"37(10)","author":"N Shafiei","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/nrclinonc.2012.88","article-title":"Translational approaches to treatment-induced symptoms in cancer patients","volume":"9(7)","author":"R Dantzer","year":"2012","journal-title":"Nat Rev Clin Oncol"},{"key":"ref83","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.bbi.2008.08.006","article-title":"Mechanisms of cytokine-induced behavioral changes: Psychoneuroimmunology at the translational interface","volume":"23","author":"AH Miller","year":"2009","journal-title":"Brain Behav Immunity"},{"key":"ref84","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1076\/1380-3395(200004)22:2;1-1;FT232","article-title":"Parkinsonian motor characteristics in unipolar major depression","volume":"22(2)","author":"MA Rogers","year":"2000","journal-title":"J Clin Exp Neuropsychol"},{"key":"ref85","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s00213-010-2015-4","article-title":"Effect of the adenosine A2A receptor antagonist MSX-3 on motivational disruptions of maternal behavior induced by dopamine antagonism in the early postpartum rat","volume":"213(1)","author":"M Pereira","year":"2011","journal-title":"Psychopharmacology"},{"key":"ref86","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S0166-2236(00)01626-X","article-title":"Negative symptoms: the \u2018pathology\u2019 of motivation and goal-directed behaviour","volume":"23(9)","author":"RG Brown","year":"2000","journal-title":"Trends Neurosci"},{"key":"ref87","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.brainresbull.2006.06.007","article-title":"Negative symptoms: A review of schizophrenia, melancholic depression and Parkinson&apos;s disease","volume":"70","author":"C Winograd-Gurvich","year":"2006","journal-title":"Brain Res Bull"},{"key":"ref88","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.biopsych.2012.12.022","article-title":"Negative symptoms of schizophrenia are associated with abnormal effort-cost computations","volume":"74(2)","author":"JM Gold","year":"2013","journal-title":"Biol Psychiatry"},{"key":"ref89","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1016\/j.neubiorev.2013.08.007","article-title":"Measuring reinforcement learning and motivation constructs in experimental animals: relevance to the negative symptoms of schizophrenia","volume":"37","author":"A Markou","year":"2013","journal-title":"Neurosci BiobehavRev"},{"key":"ref90","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1016\/j.neubiorev.2013.09.001","article-title":"Neural substrates underlying effort computation in schizophrenia","volume":"37(10 Pt 2)","author":"G Fervaha","year":"2013","journal-title":"Neurosci Biobehav Rev"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1002\/mds.23736","article-title":"Appetitive motivational deficits in individuals with Parkinson&apos;s disease","volume":"26(10)","author":"DM Shore","year":"2011","journal-title":"Mov Disord"},{"key":"ref92","doi-asserted-by":"crossref","DOI":"10.1186\/1741-7015-11-126","article-title":"Toward the future of psychiatric diagnosis: the seven pillars of RDoC","volume":"11","author":"BN Cuthbert","year":"2013","journal-title":"BMC Med"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0099320","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T23:50:24Z","timestamp":1588981824000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0099320"}},"subtitle":[],"editor":[{"given":"Harriet","family":"de Wit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,6,17]]},"references-count":92,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2014,6,17]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0099320","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,17]]}}}